SEC 13F Intelligence

New England Research & Management, Inc. / ABBV

New England Research & Management, Inc.’s Abbvie Inc Position

Does New England Research & Management, Inc. own Abbvie Inc (ABBV)? Yes — 24.8K shares worth $6M (+2.43% of its 13F portfolio) as of Q2 2026, down from 25.5K shares the prior filed quarter.

Position Value
$6M
Q2 2026
Shares
24.8K
% of Portfolio
+2.43%
Quarters Held
3
currently held

Position History ABBV

Reported value by quarter
Q4 ’25: $5MQ4 ’25Q1 ’26: $6MQ1 ’26Q2 ’26: $6MQ2 ’26filingsflow.com
QuarterSharesValue% of Portfolio
Q2 202624.8K$6M+2.43%
Q1 202625.5K$6M+2.34%
Q4 202521.6K$5M+2.16%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See New England Research & Management, Inc.’s full portfolio or all institutional holders of ABBV.